Literature DB >> 24296352

T-cell costimulatory blockade in organ transplantation.

Jonathan S Maltzman1, Laurence A Turka.   

Abstract

Before it became possible to derive T-cell lines and clones, initial experimentation on the activation requirements of T lymphocytes was performed on transformed cell lines, such as Jurkat. These studies, although technically correct, proved misleading as most transformed T cells can be activated by stimulation of the clonotypic T-cell receptor (TCR) alone. In contrast, once it became possible to study nontransformed T cells, it quickly became clear that TCR stimulation by itself is insufficient for optimal activation of naïve T cells, but in fact, induces a state of anergy. It then became clear that functional activation of T cells requires not only recognition of major histocompatibility complex (MHC) and peptide by the TCR, but also requires ligation of costimulatory receptors expressed on the cell surface.

Mesh:

Substances:

Year:  2013        PMID: 24296352      PMCID: PMC3839597          DOI: 10.1101/cshperspect.a015537

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  105 in total

1.  The structural basis for the recognition of diverse receptor sequences by TRAF2.

Authors:  H Ye; Y C Park; M Kreishman; E Kieff; H Wu
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

2.  High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

Authors:  S S Pullen; M E Labadia; R H Ingraham; S M McWhirter; D S Everdeen; T Alber; J J Crute; M R Kehry
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

3.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors:  J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

4.  Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

Authors:  Christian P Larsen; Thomas C Pearson; Andrew B Adams; Paul Tso; Nozomu Shirasugi; Elizabeth Strobert; Dan Anderson; Shannon Cowan; Karen Price; Joseph Naemura; John Emswiler; JoAnne Greene; Lori Ann Turk; Jurgen Bajorath; Robert Townsend; David Hagerty; Peter S Linsley; Robert J Peach
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

5.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.

Authors:  A Hutloff; A M Dittrich; K C Beier; B Eljaschewitsch; R Kraft; I Anagnostopoulos; R A Kroczek
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

6.  Transplantation of anergic histoincompatible bone marrow allografts.

Authors:  E C Guinan; V A Boussiotis; D Neuberg; L L Brennan; N Hirano; L M Nadler; J G Gribben
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

7.  Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.

Authors:  M G Levisetti; P A Padrid; G L Szot; N Mittal; S M Meehan; C L Wardrip; G S Gray; D S Bruce; J R Thistlethwaite; J A Bluestone
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

8.  Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.

Authors:  M A DeBenedette; T Wen; M F Bachmann; P S Ohashi; B H Barber; K L Stocking; J J Peschon; T H Watts
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

9.  4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.

Authors:  J T Tan; J K Whitmire; R Ahmed; T C Pearson; C P Larsen
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

10.  Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

Authors:  A D Kirk; L C Burkly; D S Batty; R E Baumgartner; J D Berning; K Buchanan; J H Fechner; R L Germond; R L Kampen; N B Patterson; S J Swanson; D K Tadaki; C N TenHoor; L White; S J Knechtle; D M Harlan
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

View more
  6 in total

Review 1.  Tolerance--is it worth it?

Authors:  Erik B Finger; Terry B Strom; Arthur J Matas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 2.  Novel Immunomodulatory Approaches for Porcine Islet Xenotransplantation.

Authors:  So-Hee Hong; Hyun-Je Kim; Seong-Jun Kang; Chung-Gyu Park
Journal:  Curr Diab Rep       Date:  2021-01-12       Impact factor: 4.810

3.  Cutting Edge: Early Attrition of Memory T Cells during Inflammation and Costimulation Blockade Is Regulated Concurrently by Proapoptotic Proteins Fas and Bim.

Authors:  Sonal Jangalwe; Varun N Kapoor; Jia Xu; Nomeda Girnius; Norman J Kennedy; Yvonne J K Edwards; Raymond M Welsh; Roger J Davis; Michael A Brehm
Journal:  J Immunol       Date:  2019-01-04       Impact factor: 5.422

Review 4.  Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.

Authors:  Lifang Zhao; Zhaoying Fu
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818

5.  Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro.

Authors:  Christian Binder; Felix Sellberg; Filip Cvetkovski; Erik Berglund; David Berglund
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

6.  Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade.

Authors:  Yusuke Tomita; Miwa Satomi; William Bracamonte-Baran; Ewa Jankowska Gan; Andrea Szymczak Workman; Creg J Workman; Dario Angelo Alberto Vignali; William J Burlingham
Journal:  Transplant Direct       Date:  2016-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.